399 Stock Overview
An investment holding company, engages in the trading of beauty equipment and products in the People’s Republic of China and Hong Kong.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 3/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Innovative Pharmaceutical Biotech Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | HK$0.24 |
| 52 Week High | HK$0.37 |
| 52 Week Low | HK$0.18 |
| Beta | -0.12 |
| 11 Month Change | 20.60% |
| 3 Month Change | 15.38% |
| 1 Year Change | 20.00% |
| 33 Year Change | -3.61% |
| 5 Year Change | -32.39% |
| Change since IPO | -99.79% |
Recent News & Updates
Recent updates
Innovative Pharmaceutical Biotech (HKG:399) Has Debt But No Earnings; Should You Worry?
Aug 12
Robust Earnings May Not Tell The Whole Story For Innovative Pharmaceutical Biotech (HKG:399)
Jan 05Is Innovative Pharmaceutical Biotech (HKG:399) Using Too Much Debt?
Feb 18Innovative Pharmaceutical Biotech's(HKG:399) Share Price Is Down 80% Over The Past Five Years.
Nov 26
Shareholder Returns
| 399 | HK Trade Distributors | HK Market | |
|---|---|---|---|
| 7D | 0.8% | 0.8% | -0.8% |
| 1Y | 20.0% | -8.8% | -1.1% |
Return vs Industry: 399 exceeded the Hong Kong Trade Distributors industry which returned -8.8% over the past year.
Return vs Market: 399 exceeded the Hong Kong Market which returned -1.1% over the past year.
Price Volatility
| 399 volatility | |
|---|---|
| 399 Average Weekly Movement | 9.6% |
| Trade Distributors Industry Average Movement | 8.4% |
| Market Average Movement | 7.0% |
| 10% most volatile stocks in HK Market | 14.9% |
| 10% least volatile stocks in HK Market | 3.7% |
Stable Share Price: 399 has not had significant price volatility in the past 3 months.
Volatility Over Time: 399's weekly volatility (10%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | 20 | n/a | www.ipb.asia/en/global/home.php |
Innovative Pharmaceutical Biotech Limited, an investment holding company, engages in the trading of beauty equipment and products in the People’s Republic of China and Hong Kong. The company operates in two segments, Trading of Beauty Products, and Research and Development. It is also involved in the securities investment; research, development, and commercialization of oral insulin products; distribution of bio-industrial products; healthcare management; and provision of genetic testing services.
Innovative Pharmaceutical Biotech Limited Fundamentals Summary
| 399 fundamental statistics | |
|---|---|
| Market cap | HK$387.72m |
| Earnings (TTM) | HK$103.40m |
| Revenue (TTM) | HK$6.59m |
4.0x
P/E Ratio62.7x
P/S RatioIs 399 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 399 income statement (TTM) | |
|---|---|
| Revenue | HK$6.59m |
| Cost of Revenue | HK$5.75m |
| Gross Profit | HK$840.00k |
| Other Expenses | -HK$102.56m |
| Earnings | HK$103.40m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.06 |
| Gross Margin | 12.74% |
| Net Profit Margin | 1,568.38% |
| Debt/Equity Ratio | 330.0% |
How did 399 perform over the long term?
See historical performance and comparison